These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 33234138)

  • 41. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
    Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
    Majdic G
    Front Cell Infect Microbiol; 2020; 10():327. PubMed ID: 32582576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
    Ameratunga R; Lehnert K; Leung E; Comoletti D; Snell R; Woon ST; Abbott W; Mears E; Steele R; McKee J; Muscroft-Taylor A; Ameratunga S; Medlicott N; Das S; Rolleston W; Quiñones-Mateu M; Petousis-Harris H; Jordan A
    N Z Med J; 2020 May; 133(1515):112-118. PubMed ID: 32438383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
    Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A
    Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
    Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
    Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in the incidence, mortality, and fatality of COVID-19 in Peru.
    Ramírez-Soto MC; Arroyo-Hernández H; Ortega-Cáceres G
    PLoS One; 2021; 16(6):e0253193. PubMed ID: 34125851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
    Roshanravan N; Ghaffari S; Hedayati M
    Diabetes Metab Syndr; 2020; 14(4):637-639. PubMed ID: 32428864
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Bao R; Hernandez K; Huang L; Luke JJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32675312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system.
    Huang HH; Wang PH; Yang YP; Chou SJ; Chu PW; Wu GJ; Chang CC
    J Chin Med Assoc; 2020 Oct; 83(10):895-897. PubMed ID: 33009240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression.
    Konwar C; Asiimwe R; Inkster AM; Merrill SM; Negri GL; Aristizabal MJ; Rider CF; MacIsaac JL; Carlsten C; Kobor MS
    Epigenetics Chromatin; 2021 Dec; 14(1):54. PubMed ID: 34895312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
    Mihalopoulos M; Dogra N; Mohamed N; Badani K; Kyprianou N
    Eur Urol Focus; 2020 Sep; 6(5):1086-1096. PubMed ID: 32540268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Let's talk about sex in the context of COVID-19.
    Gargaglioni LH; Marques DA
    J Appl Physiol (1985); 2020 Jun; 128(6):1533-1538. PubMed ID: 32437244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
    Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
    Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.